PARP Inhibitor Biomarkers Market Is Set To Witness High Growth Owing To Rising Personalized Cancer Care
PARP Inhibitor Biomarkers Market PARP inhibitor biomarkers are genetic biomarkers used for the identification of patients suffering from cancer who are likely to respond to PARP inhibitor treatment. These biomarkers help determine the tumor's sensitivity to particular therapies like PARP inhibitors. PARP inhibitors are a type of targeted therapy used mainly for certain types of breast cancer and ovarian cancer. They work by blocking an enzyme called poly(ADP-ribose) polymerase that is involved in repairing damaged DNA. Blocking this enzyme means cancer cells with damaged DNA cannot repair themselves, leading to cell death. The advantages are that it allows for more personalized treatment by identifying patients most likely to respond, mitigates costly PARP inhibitor treatment expenditures on non-responsive patients, and improves clinical outcomes. The need for PARP inhibitor biomarkers stems from the fact that not all cancer patients respond to PARP inhibitor therapy and t...